ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer, primarily focused on orphan and rare diseases. We are dedicated to our patients and committed to delivering medications that meet unmet needs in the current therapeutic landscape.

Company Information

April 19, 2022